DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Delafloxacin meglumineis the generic ingredient in one branded drug marketed by Melinta and is included in two NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Delafloxacin meglumine has seventy-eight patent family members in seventeen countries.
One supplier is listed for this compound.
Recent Litigation for delafloxacin meglumine
Identify potential future generic entrants
District Court Litigation
|CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA||2019-05-23|
|MERCK SHARP & DOHME CORP. v. MYLAN LABORATORIES LIMITED||2018-03-29|
|CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.||2017-12-20|
Pharmacology for delafloxacin meglumine
|Drug Class||Fluoroquinolone Antibacterial |
Synonyms for delafloxacin meglumine
|1-Deoxy-1-(methylamino)-D-glucitol 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (salt)|
|D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-3-quinolinecarboxylate (salt)|
|Delafloxacin meglumine (USAN)|
|Delafloxacin meglumine [USAN]|
|WQ-3034 AND ABT-492|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Melinta||BAXDELA||delafloxacin meglumine||POWDER;INTRAVENOUS||208611-001||Jun 19, 2017||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Melinta||BAXDELA||delafloxacin meglumine||TABLET;ORAL||208610-001||Jun 19, 2017||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Melinta||BAXDELA||delafloxacin meglumine||POWDER;INTRAVENOUS||208611-001||Jun 19, 2017||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Melinta||BAXDELA||delafloxacin meglumine||TABLET;ORAL||208610-001||Jun 19, 2017||RX||Yes||Yes||Start Trial||Start Trial||Y||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.